Artificial intelligence-based histopathology image analysis identifies a novel subset of endometrial cancers with distinct genomic features and unfavourable outcome

A Darbandsari, H Farahani, M Wiens, D Cochrane… - medRxiv, 2023 - medrxiv.org
Endometrial cancer (EC) has four molecular subtypes with strong prognostic value and
therapeutic implications. The most common subtype (NSMP; No Specific Molecular Profile) …

[HTML][HTML] AI-based histopathology image analysis reveals a distinct subset of endometrial cancers

A Darbandsari, H Farahani, M Asadi, M Wiens… - Nature …, 2024 - nature.com
Endometrial cancer (EC) has four molecular subtypes with strong prognostic value and
therapeutic implications. The most common subtype (NSMP; No Specific Molecular Profile) …

[HTML][HTML] The evolving role of morphology in endometrial cancer diagnostics: From histopathology and molecular testing towards integrative data analysis by deep …

S Fremond, VH Koelzer, N Horeweg, T Bosse - Frontiers in Oncology, 2022 - frontiersin.org
Endometrial cancer (EC) diagnostics is evolving into a system in which molecular aspects
are increasingly important. The traditional histological subtype-driven classification has …

The emerging role of molecular pathology in directing the systemic treatment of endometrial cancer

A Jamieson, T Bosse… - Therapeutic advances in …, 2021 - journals.sagepub.com
Following the discovery of the four molecular subtypes of endometrial cancer (EC) by The
Cancer Genome Atlas (TCGA) in 2013, subsequent studies used surrogate markers to …

Integration of clinical sequencing and immunohistochemistry for the molecular classification of endometrial carcinoma

E Rios-Doria, A Momeni-Boroujeni, CF Friedman… - Gynecologic …, 2023 - Elsevier
Purpose Using next generation sequencing (NGS), The Cancer Genome Atlas (TCGA)
found that endometrial carcinomas (ECs) fall under one of four molecular subtypes, and a …

Interpretable deep learning predicts the molecular endometrial cancer classification from H&E images: a combined analysis of the PORTEC randomized clinical trials

S Fremond, S Andani, VH Koelzer - SSRN, 2022 - zora.uzh.ch
Background: Endometrial Cancer (EC) is molecularly classified into the POLE-mutated
(POLE mut), mismatch-repair deficient (MMRd), p53 abnormal (p53abn) and no specific …

[HTML][HTML] Prognostic impact of pathologic features in molecular subgroups of endometrial carcinoma

M Ruscelli, T Maloberti, AG Corradini, F Rosini… - Journal of Personalized …, 2023 - mdpi.com
The molecular characterization of endometrial carcinoma (EC) has recently been included in
the ESGO/ESTRO/ESP guidelines. The study aims to evaluate the impact of integrated …

4 Refining pathologic interpretation of endometrial carcinomas: lessons learned from a nationwide study in a new era of molecular classification

E Thompson, J Huvila, S Leung, J Irving… - 2020 - ijgc.bmj.com
Objectives Molecular classification of endometrial carcinoma (EC) enables consistent
classification of tumours and provides valuable prognostic and predictive information …

Molecular classification of metastatic and recurrent endometrial endometrioid carcinoma: prognostic relevance among low‐and high‐stage tumours

A McHenry, K Devereaux, E Ryan, S Chow… - …, 2024 - Wiley Online Library
Aims Molecular classification according to The Cancer Genome Atlas (TCGA) improves
endometrial endometrioid carcinoma (EEC) prognostication and has specific treatment …

[HTML][HTML] Validation of a one-step genomics-based molecular classifier for endometrial carcinoma in a large Chinese population

N Kang, X Zhang, Z Wang, Y Dai, S Lu, W Su… - … -Research and Practice, 2024 - Elsevier
Objective The aim of this study is to delineate the molecular classification features within
Chinese endometrial cancer (EC) patients and to evaluate the concurrence between two …